BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30973939)

  • 1. T-cell derived acetylcholine aids host defenses during enteric bacterial infection with Citrobacter rodentium.
    Ramirez VT; Godinez DR; Brust-Mascher I; Nonnecke EB; Castillo PA; Gardner MB; Tu D; Sladek JA; Miller EN; Lebrilla CB; Bevins CL; Gareau MG; Reardon C
    PLoS Pathog; 2019 Apr; 15(4):e1007719. PubMed ID: 30973939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma.
    Simmons CP; Goncalves NS; Ghaem-Maghami M; Bajaj-Elliott M; Clare S; Neves B; Frankel G; Dougan G; MacDonald TT
    J Immunol; 2002 Feb; 168(4):1804-12. PubMed ID: 11823513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hypoxic exposure on immune responses of intestinal mucosa to Citrobacter colitis in mice.
    Ji Q; Zhang Y; Zhou Y; Gamah M; Yuan Z; Liu J; Cao C; Gao X; Zhang H; Ren Y; Zhang W
    Biomed Pharmacother; 2020 Sep; 129():110477. PubMed ID: 32768962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis.
    Ryz NR; Lochner A; Bhullar K; Ma C; Huang T; Bhinder G; Bosman E; Wu X; Innis SM; Jacobson K; Vallance BA
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G730-42. PubMed ID: 26336925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPV1 controls innate immunity during Citrobacter rodentium enteric infection.
    Cremin M; Tay EXY; Ramirez VT; Murray K; Nichols RK; Brust-Mascher I; Reardon C
    PLoS Pathog; 2023 Dec; 19(12):e1011576. PubMed ID: 38109366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of T helper type 17 and regulatory T cell activity in Citrobacter rodentium invasion and inflammatory damage.
    Symonds EL; Riedel CU; O'Mahony D; Lapthorne S; O'Mahony L; Shanahan F
    Clin Exp Immunol; 2009 Jul; 157(1):148-54. PubMed ID: 19659780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T cells drive goblet cell depletion during Citrobacter rodentium infection.
    Chan JM; Bhinder G; Sham HP; Ryz N; Huang T; Bergstrom KS; Vallance BA
    Infect Immun; 2013 Dec; 81(12):4649-58. PubMed ID: 24101690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection.
    Shiomi H; Masuda A; Nishiumi S; Nishida M; Takagawa T; Shiomi Y; Kutsumi H; Blumberg RS; Azuma T; Yoshida M
    Infect Immun; 2010 Jun; 78(6):2653-66. PubMed ID: 20351140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.
    Zheng Y; Valdez PA; Danilenko DM; Hu Y; Sa SM; Gong Q; Abbas AR; Modrusan Z; Ghilardi N; de Sauvage FJ; Ouyang W
    Nat Med; 2008 Mar; 14(3):282-9. PubMed ID: 18264109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice.
    Chen CC; Louie S; McCormick B; Walker WA; Shi HN
    Infect Immun; 2005 Sep; 73(9):5468-81. PubMed ID: 16113263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of the programmed death-1 receptor renders host susceptible to enteric microbial infection through impairing the production of the mucosal natural killer cell effector molecules.
    Solaymani-Mohammadi S; Lakhdari O; Minev I; Shenouda S; Frey BF; Billeskov R; Singer SM; Berzofsky JA; Eckmann L; Kagnoff MF
    J Leukoc Biol; 2016 Mar; 99(3):475-82. PubMed ID: 26467188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrobacter rodentium-induced colitis: A robust model to study mucosal immune responses in the gut.
    Koroleva EP; Halperin S; Gubernatorova EO; Macho-Fernandez E; Spencer CM; Tumanov AV
    J Immunol Methods; 2015 Jun; 421():61-72. PubMed ID: 25702536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D Is Required for ILC3 Derived IL-22 and Protection From
    Lin YD; Arora J; Diehl K; Bora SA; Cantorna MT
    Front Immunol; 2019; 10():1. PubMed ID: 30723466
    [No Abstract]   [Full Text] [Related]  

  • 14. Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen.
    Bry L; Brenner MB
    J Immunol; 2004 Jan; 172(1):433-41. PubMed ID: 14688352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL10-Deficiency in CD4⁺ T Cells Exacerbates the IFNγ and IL17 Response During Bacteria Induced Colitis.
    Seiffart V; Zoeller J; Klopfleisch R; Wadwa M; Hansen W; Buer J; Riedel C; Westendorf AM
    Cell Physiol Biochem; 2015; 36(4):1259-73. PubMed ID: 26160212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium.
    Bry L; Brigl M; Brenner MB
    Infect Immun; 2006 Jan; 74(1):673-81. PubMed ID: 16369024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic levels of vasoactive intestinal peptide decrease during infection and exogenous VIP protects epithelial mitochondria against the negative effects of IFNγ and TNFα induced during Citrobacter rodentium infection.
    Maiti AK; Sharba S; Navabi N; Lindén SK
    PLoS One; 2018; 13(9):e0204567. PubMed ID: 30252907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tpl2 Promotes Innate Cell Recruitment and Effector T Cell Differentiation To Limit Citrobacter rodentium Burden and Dissemination.
    Acuff NV; Li X; Latha K; Nagy T; Watford WT
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28760932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens.
    Song X; Zhu S; Shi P; Liu Y; Shi Y; Levin SD; Qian Y
    Nat Immunol; 2011 Oct; 12(12):1151-8. PubMed ID: 21993849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-36R signaling integrates innate and adaptive immune-mediated protection against enteropathogenic bacteria.
    Ngo VL; Abo H; Kuczma M; Szurek E; Moore N; Medina-Contreras O; Nusrat A; Merlin D; Gewirtz AT; Ignatowicz L; Denning TL
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27540-27548. PubMed ID: 33087566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.